BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 24952029)

  • 1. Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy: comparison with the Glasgow prognostic score.
    Matsuda S; Takeuchi H; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Kitagawa Y
    Ann Surg Oncol; 2015 Jan; 22(1):302-10. PubMed ID: 24952029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High preoperative plasma fibrinogen and serum albumin score is associated with poor survival in operable esophageal squamous cell carcinoma.
    Sun SY; Chen PP; Meng LX; Li L; Mo ZX; Sun CH; Wang Y; Liang FH
    Dis Esophagus; 2019 Jan; 32(1):. PubMed ID: 29905761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cumulative score based on preoperative plasma fibrinogen and serum C-reactive protein could predict long-term survival for esophageal squamous cell carcinoma.
    Tian R; Yan H; Zhang F; Sun P; Wu AR; Zhang M; Jiang YL; Wu J; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
    Oncotarget; 2016 Sep; 7(38):61533-61543. PubMed ID: 27517497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Impact of Change in the Fibrinogen and Albumin Score During Preoperative Treatment in Esophageal Cancer Patients.
    Matsuda S; Takeuchi H; Kawakubo H; Fukuda K; Nakamura R; Suda K; Wada N; Kitagawa Y
    World J Surg; 2017 Nov; 41(11):2788-2795. PubMed ID: 28608015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative Glasgow Prognostic Score as additional independent prognostic parameter for patients with esophageal cancer after curative esophagectomy.
    Lindenmann J; Fink-Neuboeck N; Avian A; Pichler M; Habitzruther M; Maier A; Smolle-Juettner FM
    Eur J Surg Oncol; 2017 Feb; 43(2):445-453. PubMed ID: 27839896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.
    Ma Q; Liu W; Jia R; Jiang F; Duan H; Lin P; Zhang L; Long H; Zhao H; Ma G
    World J Surg Oncol; 2016 May; 14():141. PubMed ID: 27151090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative scores based on plasma D-dimer and serum albumin levels predict survival in esophageal squamous cell carcinoma patients treated with transthoracic esophagectomy.
    Liu DQ; Li FF; Jia WH
    Chin J Cancer; 2016 Jan; 35():11. PubMed ID: 26754834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of plasma fibrinogen level as a predictive marker for postoperative recurrence of esophageal squamous cell carcinoma in patients receiving neoadjuvant treatment.
    Matsuda S; Takeuchi H; Fukuda K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
    Dis Esophagus; 2014; 27(7):654-61. PubMed ID: 23980622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma.
    Tian R; Zhang F; Sun P; Wu J; Yan H; Wu AR; Zhang M; Jiang YL; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
    Oncotarget; 2016 Oct; 7(41):67485-67494. PubMed ID: 27528228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in modified Glasgow prognostic score after neoadjuvant chemotherapy is a prognostic factor in clinical stage II/III esophageal cancer.
    Otowa Y; Nakamura T; Takiguchi G; Tomono A; Yamamoto M; Kanaji S; Imanishi T; Suzuki S; Tanaka K; Itoh T; Kakeji Y
    Dis Esophagus; 2016; 29(2):146-51. PubMed ID: 25515972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
    Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM
    Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma fibrinogen levels are correlated with postoperative distant metastasis and prognosis in esophageal squamous cell carcinoma.
    Zhang D; Zhou X; Bao W; Chen Y; Cheng L; Qiu G; Sheng L; Ji Y; Du X
    Oncotarget; 2015 Nov; 6(35):38410-20. PubMed ID: 26334098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative plasma hyperfibrinogenemia is predictive of poor prognosis in patients with nonmetastatic colon cancer.
    Son HJ; Park JW; Chang HJ; Kim DY; Kim BC; Kim SY; Park SC; Choi HS; Oh JH
    Ann Surg Oncol; 2013 Sep; 20(9):2908-13. PubMed ID: 23612884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hamburg-Glasgow classification: preoperative staging by combination of disseminated tumour load and systemic inflammation in oesophageal carcinoma.
    Reeh M; Ghadban T; Uzunoglu FG; Nentwich MF; Bockhorn M; Pantel K; Izbicki JR; Vashist YK
    Br J Cancer; 2017 Aug; 117(5):612-618. PubMed ID: 28704837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of preoperative absolute peripheral monocyte count in esophageal squamous cell carcinoma.
    Han L; Jia Y; Song Q; Wang N; Wang J; Bai B; Chen X; Wang C; Cheng Y
    Dis Esophagus; 2016 Oct; 29(7):740-746. PubMed ID: 26316375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors and causes of death in patients cured of esophageal cancer.
    Kakuta T; Kosugi S; Kanda T; Ishikawa T; Hanyu T; Suzuki T; Wakai T
    Ann Surg Oncol; 2014 May; 21(5):1749-55. PubMed ID: 24510184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of hyperfibrinogenemia in patients with esophageal squamous cell carcinoma.
    Suzuki T; Shimada H; Nanami T; Oshima Y; Yajima S; Washizawa N; Kaneko H
    Int J Clin Oncol; 2017 Jun; 22(3):461-468. PubMed ID: 28064398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation Study of Fibrinogen and Albumin Score in Esophageal Cancer Patients Who Underwent Esophagectomy: Multicenter Prospective Cohort Study.
    Matsuda S; Takeuchi H; Kawakubo H; Takemura R; Maeda Y; Hirata Y; Kaburagi T; Egawa T; Nishi T; Ogura M; Miyasho T; Okamura A; Mayanagi S; Fukuda K; Nakamura R; Irino T; Wada N; Kitagawa Y
    Ann Surg Oncol; 2021 Feb; 28(2):774-784. PubMed ID: 32737701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil followed by esophagectomy in patients with resectable node-positive esophageal cancer.
    Watanabe M; Baba Y; Yoshida N; Ishimoto T; Nagai Y; Iwatsuki M; Iwagami S; Baba H
    Ann Surg Oncol; 2014 Sep; 21(9):2838-44. PubMed ID: 24715216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of inflammation-based prognostic score on survival after curative thoracoscopic esophagectomy for esophageal cancer.
    Hirahara N; Matsubara T; Hayashi H; Takai K; Fujii Y; Tajima Y
    Eur J Surg Oncol; 2015 Oct; 41(10):1308-15. PubMed ID: 26235238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.